MedInsight Research Institute and Ariel University Center for Drug Repurposing present new pterygium/pinguecula treatment results at Israeli Ophthalmology Conference.
Tag: Eye Health / Blindness
Sylentis reports positive Phase II results with SYL1001 in treating ocular pain
Sylentis, a pharmaceutical company in the PharmaMar Group (MSE:PHM) and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has presented the…
Starving eye cells contribute to blindness in elders
Unable to produce energy, photoreceptors trigger age-related macular degeneration.
Fish and insects guide design for future contact lenses
NIH-funded researchers seek alternative to current options for a common eye disorder.
Higher ozone, lower humidity levels associated with dry eye disease, although no link with certain particulate matter level
In a study published online by JAMA Ophthalmology, Dong Hyun Kim, M.D., of Gachon University Gil Medical Center, Incheon, Korea and colleagues examined the associations between outdoor air…
Periorbital transplantation may be promising alternative to protect vision in facial transplant candidates
Transplantation of the periorbital tissues–the area surrounding the eyes–is a “technically feasible” alternative to protect a functioning eye in some patients being considered for facial…
Eye lens regeneration from own stem cells: ‘a paradigm shift in cataract surgery’
In a small trial, children in China born with cataracts regrew new eye lenses following surgery that removes diseased lenses but leaves lens capsules and own stem cells intact.
Man has distorted vision after inhaling poppers
A 52-year-old man developed distorted vision after inhaling poppers for the first time.
FDA permits marketing of device that senses optimal time to check patient’s eye pressure
The U.S. Food and Drug Administration has allowed marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient’s intraocular pressure…
New research links mitochondrial dysfunction to the development of Fuchs’ Endothelial Corneal Dystrophy (FECD)
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs…
Understanding the mechanism of rare blinding disorder passed from parents to their children
Scientists have identified a key mechanism that damages the cornea in Meesmann epithelial corneal dystrophy, a rare blinding disorder, which is passed from parents to their children.
Current vision screening recommendations for older adults have merit
The chair of ophthalmology at the University of Michigan examined a recent report investigating the value of vision screening for older adults with no symptoms.
Eylea outperforms Avastin for diabetic macular edema with moderate or worse vision loss
A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those…
108 million people have correctable vision impairment, global study estimates
Uncorrected refractive error (URE)–nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses–is responsible for moderate to severe vision impairment in 101…
Research offers hope for better treatments for retinal degenerative diseases
Two studies advance scientific understanding of a safe method for producing retinal pigment epithelial-like cells for transplantation and an effective way to repair the damaged substrate beneath…
Waterloo vision scientists discover potential treatment for adults with lazy eye
A new treatment for adults with lazy eye, a condition previously thought to be treatable only in childhood, is one step closer as a result of research from the University of Waterloo in Canada and…
Kellogg researchers develop new nanoparticle with potential to treat ocular cancer
Using nanoparticles to kill tumor cells inside the eye.Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective…
Half the world to be short-sighted by 2050
Half the world’s population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends…
Scientists discover genetic changes linked to a major risk factor for blinding trachoma
Another clue to the workings of trachoma – the world’s leading infectious cause of blindness – has been revealed in a new study published in BMC Infectious Diseases.
Using the physics of your perfect pancake to help save sight
Understanding the textures and patterns of pancakes is helping UCL scientists improve surgical methods for treating glaucoma.